Delving into the Latest Updates on Jinzhen Oral Liquid with Synapse

Overview

Basic Info

Drug Type

Herbal medicine

Synonyms-

Target-

Action-

Mechanism-

Therapeutic Areas

Infectious DiseasesRespiratory Diseases

Active Indication

Acute BronchitisPneumonia, Viral

Inactive Indication-

Originator Organization

Jiangsu Kanion Pharmaceutical Co., Ltd.

Active Organization

Jiangsu Kanion Pharmaceutical Co., Ltd.

Inactive Organization-

Drug Highest PhaseApproved

First Approval Date

China (01 Jan 1997),

Acute Bronchitis

Regulation-

Login to view timeline

1. To preliminarily evaluate the effectiveness and safety of Jinzhen oral liquid in the treatment of acute bronchitis (phlegm-heat obstructing the lungs); 2. To explore the optimal dosage of Jinzhen oral liquid in the treatment of acute bronchitis (phlegm-heat obstructing the lungs) to provide a basis for Phase III clinical trials.

Start Date18 Mar 2024

Sponsor / Collaborator

Jiangsu Kanion Pharmaceutical Co., Ltd.

CTR20231958

/ RecruitingPhase 2

金振口服液治疗轻症儿童病毒性肺炎的多中心、随机双盲、多剂量平行对照临床试验

[Translation] A multicenter, randomized, double-blind, multi-dose parallel controlled clinical trial of Jinzhen oral liquid in the treatment of mild viral pneumonia in children

进行剂量探索，并初步评价不同剂量金振口服液治疗轻症儿童病毒性肺炎的有效性和安全性。

[Translation]

Conduct dose exploration and preliminarily evaluate the efficacy and safety of different doses of Jinzhen oral liquid in the treatment of mild viral pneumonia in children.

Start Date13 Oct 2023

Sponsor / Collaborator

Jiangsu Kanion Pharmaceutical Co., Ltd.

100 Clinical Results associated with Jinzhen Oral Liquid

Login to view more data

100 Translational Medicine associated with Jinzhen Oral Liquid

Login to view more data

100 Patents (Medical) associated with Jinzhen Oral Liquid

Login to view more data

100 Deals associated with Jinzhen Oral Liquid

Login to view more data